Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update

被引:327
作者
Hollenberg, SM
Ahrens, TS
Annane, D
Astiz, ME
Chalfin, DB
Dasta, JF
Heard, SO
Martin, C
Napolitano, LM
Susla, GM
Totaro, R
Vincent, JL
Zanotti-Cavazzoni, S
机构
关键词
sepsis; hemodynamic support; fluid resuscitation; vasopressor therapy; inotropic therapy;
D O I
10.1097/01.CCM.0000139761.05492.D6
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective. To provide the American College of Critical Care Medicine with updated guidelines for hemodynamic support of adult patients with sepsis. Data Source., Publications relevant to hemodynamic support of septic patients were obtained from the medical literature, supplemented by the expertise and experience of members of an international task force convened from the membership of the Society of Critical Care Medicine. Study Selection. Both human studies and relevant animal studies were considered. Data Synthesis: The experts articles reviewed the literature and classified the strength of evidence of human studies according to study design and scientific value. Recommendations were drafted and graded levels based on an evidence-based rating system described in the text. The recommendations were de-bated, and the task force chairman modified the document until <10% of the experts disagreed with the recommendations. 4Conclusions. An organized approach to the hemodynamic support of sepsis was formulated. The fundamental principle is that clinicians using hemodynamic therapies should define specific goals and end points, titrate therapies to those end points, and evaluate the results of their interventions on an ongoing basis by monitoring a combination of variables of global and regional perfusion. Using this approach, specific recommendations for fluid resuscitation, vasopressor therapy, and inotropic therapy of septic in adult patients were promulgated.
引用
收藏
页码:1928 / 1948
页数:21
相关论文
共 230 条
[61]   EFFECTS OF NOREPINEPHRINE ON RENAL-FUNCTION IN SEPTIC PATIENTS WITH NORMAL AND ELEVATED SERUM LACTATE LEVELS [J].
FUKUOKA, T ;
NISHIMURA, M ;
IMANAKA, H ;
TAENAKA, N ;
YOSHIYA, I ;
TAKEZAWA, J .
CRITICAL CARE MEDICINE, 1989, 17 (11) :1104-1107
[62]   Hextend®, a physiologically balanced plasma expander for large volume use in major surgery:: A randomized phase III clinical trial [J].
Gan, TJ ;
Bennett-Guerrero, E ;
Phillips-Bute, B ;
Wakeling, H ;
Moskowitz, DM ;
Olufolabi, Y ;
Konstadt, SN ;
Bradford, C ;
Glass, PSA ;
Machin, SJ ;
Mythen, MG .
ANESTHESIA AND ANALGESIA, 1999, 88 (05) :992-998
[63]   A TRIAL OF GOAL-ORIENTED HEMODYNAMIC THERAPY IN CRITICALLY ILL PATIENTS [J].
GATTINONI, L ;
BRAZZI, L ;
PELOSI, P ;
LATINI, R ;
TOGNONI, G ;
PESENTI, A ;
FUMAGALLI, R .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (16) :1025-1032
[64]   THE EFFECT OF FLUID LOADING, BLOOD-TRANSFUSION, AND CATECHOLAMINE INFUSION ON OXYGEN DELIVERY AND CONSUMPTION IN PATIENTS WITH SEPSIS [J].
GILBERT, EM ;
HAUPT, MT ;
MANDANAS, RY ;
HUARINGA, AJ ;
CARLSON, RW .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1986, 134 (05) :873-878
[65]   Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen availability [J].
Gore, DC ;
Jahoor, F ;
Hibbert, JM ;
DeMaria, EJ .
ANNALS OF SURGERY, 1996, 224 (01) :97-102
[66]  
GOTLOIB L, 1992, CIRC SHOCK, V36, P45
[67]  
GREENFIELD LJ, 1974, SURGERY, V76, P560
[68]   EXPERIENCE WITH PHENYLEPHRINE AS A COMPONENT OF THE PHARMACOLOGICAL SUPPORT OF SEPTIC SHOCK [J].
GREGORY, JS ;
BONFIGLIO, MF ;
DASTA, JF ;
REILLEY, TE ;
TOWNSEND, MC ;
FLANCBAUM, L .
CRITICAL CARE MEDICINE, 1991, 19 (11) :1395-1400
[69]   GLUCOCORTICOIDS MODULATE VASCULAR REACTIVITY IN THE RAT [J].
GRUNFELD, JP ;
ELOY, L .
HYPERTENSION, 1987, 10 (06) :608-618
[70]   INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR INHIBIT CARDIAC MYOCYTE BETA-ADRENERGIC RESPONSIVENESS [J].
GULICK, T ;
CHUNG, MK ;
PIEPER, SJ ;
LANGE, LG ;
SCHREINER, GF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (17) :6753-6757